Login / Signup

The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant.

Marcia M L KhoMarlies E J ReindersCarla C BaanDebbie van BaarleFrederike J BemelmanDimitri A DiavatopoulosRon T GansevoortFiona R M van der KlisMarion P G KoopmansA Lianne MesschendorpRenate G van der MolenEster B M RemmerswaalNynke RotsPriya VartRory D de VriesLuuk B HilbrandsJan-Stephan F Sandersnull null
Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2021)
Keyphrases
  • immune response
  • coronavirus disease
  • sars cov
  • chronic kidney disease
  • end stage renal disease
  • dendritic cells
  • toll like receptor
  • binding protein
  • inflammatory response